VISTAGEN THERAPEUTICS, INC. Earnings Per Share (Basic)
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Earnings Per Share (Basic) of -$0.30 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.30.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.45.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.54.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.47.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for fiscal 2026 was -$1.83.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$1.67.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$1.52.
- VISTAGEN THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$8.51.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.30 10-Q · filed 2026-08-14 | |||||||
| 2026-03-31 | -$1.83 10-K · filed 2026-06-15 | |||||||
| 2025-12-31 | -$0.45 10-Q · filed 2026-02-12 | -$1.46 10-Q · filed 2026-02-12 | ||||||
| 2025-09-30 | -$0.54 10-Q · filed 2025-11-13 | -$1.02 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$0.47 10-Q · filed 2026-08-14 | |||||||
| 2025-03-31 | -$1.67 10-K · filed 2026-06-15 | |||||||
| 2024-12-31 | -$0.46 10-Q · filed 2026-02-12 | -$1.23 10-Q · filed 2026-02-12 | ||||||
| 2024-09-30 | -$0.42 10-Q · filed 2025-11-13 | -$0.77 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | -$0.35 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | -$1.52 10-K · filed 2025-06-17 | |||||||
| 2023-12-31 | -$0.22 10-Q · filed 2025-02-13 | -$1.27 10-Q · filed 2025-02-13 | ||||||
| 2023-09-30 | -$0.66 10-Q · filed 2024-11-07 | -$1.55 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$0.94 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | -$1.71 10-K · filed 2023-06-28 | -$3.13 derived: net income ÷ weighted average shares · filed 2024-02-13 | -$5.65 derived: net income ÷ weighted average shares · filed 2024-02-13 | -$8.51 10-K · filed 2024-06-11 | ||||
| 2022-12-31 | -$1.42 10-Q · filed 2024-02-13 | -$0.05 10-Q · filed 2023-02-07 | -$3.95 derived: net income ÷ weighted average shares · filed 2024-02-13 | -$6.82 10-Q · filed 2024-02-13 | -$0.23 10-Q · filed 2023-02-07 | -$9.25 derived: net income ÷ weighted average shares · filed 2024-02-13 | ||
| 2022-09-30 | -$2.54 10-Q · filed 2023-11-09 | -$0.08 10-Q · filed 2022-11-10 | -$5.41 10-Q · filed 2023-11-09 | -$0.18 10-Q · filed 2022-11-10 | -$7.83 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$9.44 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||
| 2022-06-30 | -$2.87 10-Q · filed 2023-08-10 | -$0.10 10-Q · filed 2022-08-11 | -$5.30 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$6.90 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$8.96 derived: net income ÷ weighted average shares · filed 2023-08-10 | |||
| 2022-03-31 | -$2.42 10-K · filed 2023-06-28 | -$0.08 10-K · filed 2022-06-23 | -$4.03 derived: net income ÷ weighted average shares · filed 2023-06-28 | -$6.07 derived: net income ÷ weighted average shares · filed 2023-06-28 | -$7.38 10-K · filed 2023-06-28 | -$0.25 10-K · filed 2022-06-23 | ||
| 2021-12-31 | -$1.59 10-K · filed 2023-06-28 | -$0.05 10-K · filed 2022-06-23 | -$3.63 derived: net income ÷ weighted average shares · filed 2023-06-28 | -$0.16 10-Q · filed 2023-02-07 | ||||
| 2021-09-30 | -$2.04 10-K · filed 2023-06-28 | -$0.07 10-K · filed 2022-06-23 | -$0.11 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$1.28 10-K · filed 2023-06-28 | -$0.04 10-K · filed 2022-06-23 | ||||||
| 2021-03-31 | -$0.49 10-K · filed 2022-06-23 | |||||||
| 2016-03-31 | -$4.44 derived: net income ÷ weighted average shares · filed 2017-06-29 | -$6.63 derived: net income ÷ weighted average shares · filed 2017-06-29 | -$11.66 derived: net income ÷ weighted average shares · filed 2017-06-29 | -$29.08 10-K · filed 2016-06-24 | ||||
| 2015-12-31 | -$1.95 10-Q · filed 2016-02-16 | -$7.08 derived: net income ÷ weighted average shares · filed 2017-06-29 | -$25.45 10-Q · filed 2016-02-16 | |||||
| 2015-09-30 | -$5.26 10-Q · filed 2015-11-16 | -$24.21 10-Q · filed 2015-11-16 | ||||||
| 2015-03-31 | -$4.24 10-K · filed 2016-06-24 | -$5.28 derived: net income ÷ weighted average shares · filed 2016-06-24 | -$6.92 derived: net income ÷ weighted average shares · filed 2016-06-24 | -$10.53 10-K · filed 2016-06-24 | ||||
| 2014-12-31 | -$0.84 10-K · filed 2016-06-24 | -$2.41 derived: net income ÷ weighted average shares · filed 2016-06-24 | -$6.03 10-Q · filed 2016-02-16 | -$6.54 derived: net income ÷ weighted average shares · filed 2016-06-24 | ||||
| 2014-09-30 | -$1.58 10-K · filed 2016-06-24 | -$5.24 10-Q · filed 2015-11-16 | -$5.76 derived: net income ÷ weighted average shares · filed 2016-06-24 | -$6.30 derived: net income ÷ weighted average shares · filed 2016-06-24 | ||||
| 2014-06-30 | -$3.70 10-K · filed 2016-06-24 | -$0.19 10-Q · filed 2014-08-12 | -$4.20 derived: net income ÷ weighted average shares · filed 2016-06-24 | -$4.72 derived: net income ÷ weighted average shares · filed 2016-06-24 | -$6.16 derived: net income ÷ weighted average shares · filed 2016-06-24 | |||
| 2014-03-31 | -$1.57 10-K · filed 2015-06-29 | -$0.84 derived: net income ÷ weighted average shares · filed 2015-06-29 | -$2.24 derived: net income ÷ weighted average shares · filed 2015-06-29 | -$2.70 10-K · filed 2015-06-29 | -$0.14 10-K · filed 2014-06-25 | |||
| 2013-12-31 | $0.12 10-K · filed 2015-06-29 | $0.01 10-Q · filed 2014-02-14 | -$1.86 derived: net income ÷ weighted average shares · filed 2015-02-17 | -$1.06 10-Q · filed 2015-02-17 | -$0.05 10-Q · filed 2014-02-14 | $1.30 derived: net income ÷ weighted average shares · filed 2015-02-17 | ||
| 2013-09-30 | -$1.35 10-K · filed 2015-06-29 | -$1.20 10-Q · filed 2014-11-19 | $1.03 derived: net income ÷ weighted average shares · filed 2014-11-19 | $0.15 derived: net income ÷ weighted average shares · filed 2014-11-19 | ||||
| 2013-06-30 | $0.18 10-K · filed 2015-06-29 | $0.01 10-Q · filed 2013-08-14 | $0.76 derived: net income ÷ weighted average shares · filed 2014-08-12 | $0.18 derived: net income ÷ weighted average shares · filed 2014-08-12 | ||||
| 2013-03-31 | $0.63 derived: net income ÷ weighted average shares · filed 2014-08-12 | $0.16 derived: net income ÷ weighted average shares · filed 2014-08-12 | $0.01 10-Q · filed 2014-08-12 | -$1.27 10-K · filed 2014-06-25 | ||||
| 2012-12-31 | -$0.85 10-Q · filed 2014-02-14 | -$1.11 10-Q · filed 2014-02-14 | ||||||
| 2012-06-30 | -$0.11 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |